Who We Are
Oyasin AI is building the next generation of explainable, multimodal AI for pharmaceutical promotional review. Our platform helps Medical, Legal, and Regulatory teams identify compliance risks, strengthen scientific evidence, and prepare high-quality content before formal MLR review.
AI Innovation
Developing explainable AI purpose-built for pharmaceutical compliance.
Scientific Foundation
Built by researchers with deep expertise in life sciences, translational research, and regulatory science.
Real-World Impact
Helping pharmaceutical teams improve review quality, reduce risk, and accelerate access to trusted medical information.
The Story Behind Oyasin AI
Every great innovation begins with a problem worth solving.
We saw an industry where pharmaceutical teams spend countless hours reviewing promotional materials, connecting claims to evidence, and ensuring compliance across increasingly complex regulatory requirements. Existing tools often focus on isolated tasks, leaving experts to manually connect the bigger picture.
Oyasin AI was created to change that. By combining explainable artificial intelligence with scientific and regulatory expertise, we are building technology that understands the full context of promotional content and helps Medical, Legal, and Regulatory teams make faster, more confident decisions.
Our mission is simple: empower experts with trustworthy AI that strengthens compliance, accelerates review, and ultimately supports better scientific communication for patients worldwide.
Leadership Team
A multidisciplinary team combining expertise in pharmaceutical science, regulatory affairs, business strategy, and artificial intelligence.
Hossein Abdeahad, MS, PhD
Co-Founder & Chief Executive Officer
Leads Oyasin AI’s vision, strategy, and business growth. Experienced scientist driving innovation at the intersection of AI and pharmaceutical compliance.
Kashif Pervaiz Pharm-D, MBA , DBA
Co-Founder & Chief Scientific Officer
Medical affairs and regulatory expert with 10+ years of experience in pharmaceutical commercialization, MLR review, and scientific communications.
Younes Abdeahad, MS
Chief Technology Officer
Leads software engineering and AI platform development, building secure, scalable systems that transform complex regulatory workflows into intelligent digital solutions.
Majid Memari, PhD
AI Advisor
Assistant Professor at Utah Valley University and NVIDIA Ambassador. Provides strategic guidance on AI architecture, machine learning, and scalable intelligent systems.
Our Vision
We envision a future where every pharmaceutical team is supported by intelligent, explainable AI that strengthens scientific communication, reduces compliance risk, and accelerates access to trusted therapies.
Oyasin AI is building technology that helps experts make better decisions—not replaces them. By combining artificial intelligence with scientific and regulatory expertise, we aim to transform the way promotional content is reviewed across the life sciences industry.
Let’s Start the Conversation
Whether you’re interested in a pilot program, partnership, investment opportunity, or simply want to learn more about Oyasin AI, we’d love to hear from you
Salt Lake City, Utah, USA